XI'AN,
China, June 16, 2022 /PRNewswire/ -- Bon Natural
Life Limited (Nasdaq: BON) ("BON" or the "Company"), one of the
leading bio-ingredient solutions providers in the natural, health
and personal care industries, today announced that it has launched
a new cruciferous vegetable based probiotic powder drink that could
potentially inhibit the proliferation of Helicobacter pylori and
help regulate the digestive system. The powder drink is the first
proprietary product of BON's cruciferous vegetable based health
supplement series.
"We believe that the successful rollout of this new powder drink
will provide an additional growth driver for BON and capitalize the
increasing awareness and consumption of multifunctional probiotics
both during and post COVID-19 pandemic. We are confident that the
new nutraceutical series will enable us to enter into a whole new
era of growth." Commented Mr. Yongwei
Hu, CEO and Chairman of BON, "H. pylori infection has become
a major global health problem. According to the research by Hooi
and etc.[1], approximately 55.8% of the Chinese
population were infected with H. pylori in 2017, which provides BON
with a huge market potential for our broccoli sprout based
probiotic powder drink. According to Euromonitor[2], the
market size of probiotics increased by 173.9% from US$7.3 billion (approximately 48.6 billion yuan) in 2015 to about US$12.7 billion (approximately 85 billion yuan) in 2020 in China, with a compound growth rate of 11.83%
in China. China has become the third largest probiotics
consumption country after the U.S. and Italy in2017."
By formulating three different kinds of patented probiotics with
sulforaphane, a chemical compound extracted from broccoli, and
fucoidan, a compound extracted from seaweed, BON is able to
leverage its innovative technology to develop a product with
potential anti-pylori effect. Additionally, this powder drink could
also regulate and improve one's overall microbiome and digestive
health.
About Helicobacter pylori (H. pylori)
H. pylori is a bacterial pathogen that infects over 50 percent
of the world population. It has been identified as a Group I
carcinogen by the World Health Organization[3]. As a
result of the H. pylori infection, infected patients develop a
range of pathologies including gastric cancer, peptic ulcer
disease, and mucosa-associated lymphoid tissue (MALT) lymphoma. The
eradication rate of (H. pylori has been decreasing, mainly due to
high resistance of H. pylori to antibiotics which are commonly used
in standard treatment.
About Bon Natural Life Limited
The Company focuses on the manufacturing of personal care
ingredients, such as plant extracted fragrance compounds for
perfume and fragrance manufacturers, natural health supplements
such as powder drinks and bioactive food ingredient products mostly
used as food additives and nutritional supplements by their
customers. For additional information, please visit the Company's
website at www.bnlus.com.
Safe Harbor Statement
This press release contains forward-looking statements as
defined by the Private Securities Litigation Reform Act of 1995.
Forward-looking statements include statements concerning plans,
objectives, goals, strategies, future events or performance, and
underlying assumptions and other statements that are other than
statements of historical facts. When the Company uses words such as
"may, "will, "intend," "should," "believe," "expect," "anticipate,"
"project," "estimate" or similar expressions that do not relate
solely to historical matters, it is making forward-looking
statements. Forward-looking statements are not guarantees of future
performance and involve risks and uncertainties that may cause the
actual results to differ materially from the Company's expectations
discussed in the forward-looking statements. These statements are
subject to uncertainties and risks including, but not limited to,
the following: the Company's goals and strategies; the Company's
future business development; product and service demand and
acceptance; changes in technology; economic conditions; the growth
of the natural, health and personal care market
in China and the other international markets the Company
plans to serve; reputation and brand; the impact of competition and
pricing; government regulations; fluctuations in general economic
and business conditions in China and the international
markets the Company plans to serve and assumptions underlying or
related to any of the foregoing and other risks contained in
reports filed by the Company with the SEC. For these reasons, among
others, investors are cautioned not to place undue reliance upon
any forward-looking statements in this press release. Additional
factors are discussed in the Company's filings with the SEC, which
are available for review at www.sec.gov. The Company
undertakes no obligation to publicly revise these forward–looking
statements to reflect events or circumstances that arise after the
date hereof.
For more information, please contact:
In the United
States:
Maggie Zhang | Impact IR
Sophie Zhang | Impact IR
Phone: (646) 893-8916
Phone: (786)
953-2513
Email: maggie.zhang@irimpact.com
Email:
sophie.zhang@irimpact.com
[1]https://www.sciencedirect.com/science/article/pii/S0016508517355312
[2]https://market.chemlinked.com/industry/probiotics-increases-presence-in-chinas-consumer-goods-market
[3]https://www.niehs.nih.gov/news/newsroom/releases/2021/december21/index.cfm
View original
content:https://www.prnewswire.com/news-releases/bon-natural-life-limited-introduces-new-powder-drink-for-anti-h-pylori-and-digestive-health-301569210.html
SOURCE Bon Natural Life Limited